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Echinococcoses 
and Tibetan 
Communities 
To the Editor: The People’s Re-
public of China accounts for >500,000 
cases of echinococcosis and more dis-
ability-associated life years (DALYs) 
lost because of this disease than any 
other world region (1,2). Hydatid 
cysts of Echinococcus granulosus 
(cystic echinococcosis [CE]), or the 
more pathogenic lesions with mul-
tiple vesicles caused by E. multilocu-
laris infection (alveolar echinococ-
cosis [AE]), usually grow slowly in 
the liver, so that severe illness and 
death may eventually occur in a high 
proportion of those with untreated 
infections (3,4). Apart from surgery, 
long-term anthelminthic therapy (>6 
months) with the benzimidazole com-
pound albendazole, although parasito-
static only, has a beneﬁ  cial outcome 
in >50% of cases (5). To control the 
transmission of this zoonosis, veteri-
nary public health measures must be 
emphasized (6).
In 2004 the Chinese Ministry of 
Health (MoH) undertook a nationwide 
assessment of 8 parasitic diseases, 
including malaria, schistosomiasis, 
and echinococcosis. To identify echi-
nococcosis, 7 provincial MoHs car-
ried out a mass abdominal screening 
of 34,500 persons using portable ul-
trasound scanners. The overall preva-
lence (2.5%) was highest in Tibetan 
communities in the Tibet Autonomous 
Region and in northwestern Sichuan 
and Qinghai Provinces (these latter 
regions form part of the eastern Ti-
betan Plateau). Collaborative studies 
involving the Sichuan Center for Dis-
ease Control and Prevention (based in 
Chengdu) and an international con-
sortium of research institutes partly 
funded by the US National Institutes 
of Health (Bethesda, MD, USA) have 
shown an increasingly serious public 
health problem at the village, township, 
and county levels. In Shiqu County 
of Ganze Tibetan Autonomous Pre-
fecture, 414 (12.9%) of nearly 3,199 
persons surveyed by ultrasound (with 
serologic conﬁ  rmation) exhibited CE 
or AE, including 19% in this category 
(7). The effects of human echinococ-
cosis are substantial, with >50,000 
DALYs lost in a population of 63,000 
in Shiqu County (8).
Despite increased urbanization 
in China, >70% of Tibetans still live 
as seminomadic pastoralists on the 
high grasslands at an altitude >3,500 
m. Most Tibetan herdsmen families 
keep at least 1 dog, and large numbers 
of ownerless stray dogs are tolerated 
by pastoralists and Buddhist monks. 
Risk factors for human echinococ-
cosis (both CE and AE) in Tibetan 
communities usually include occupa-
tion, age (older persons are at higher 
risk), gender (higher risk for female), 
environment (pastoral landscapes), 
livestock ownership, and a history of 
dog ownership, as well as indicators 
of low socioeconomic status, includ-
ing poor water quality and illiteracy 
(7,9) The prevalence levels of human 
AE in Ganze Tibetan Autonomous 
Prefecture (Sichuan Province) are 
among the highest recorded anywhere 
in the world. This situation presents a 
formidable challenge for early diag-
nosis, optimal affordable treatment, 
and prevention and control. Markham 
Hospital in Aba Tibetan Autonomous 
Prefecture (Sichuan) performed 1,200 
operations for echinococcosis from 
1992 through 2005, 20% for AE 
disease. For remote, high-altitude, 
pastoral Tibetan communities, how-
ever, long-term albendazole therapy 
is the only realistic treatment option, 
but regular follow-up of patients is 
difﬁ   cult in these poorly accessible 
communities.
To address the public health con-
cerns and consider options for control-
ling hydatidosis/echinococcosis in the 
eastern Tibetan Plateau, an Interna-
tional Workshop on Treatment, Pre-
vention and Control of Echinococco-
sis was held in Chengdu in May 2006 
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with support from the Sichuan Center 
for Disease Control and Prevention, 
MoH Beijing, the New Zealand Inter-
national Aid and Development Agency 
[NZIAD]), Fogarty-National Institutes 
of Health (USA), Xinjiang Medical 
University, and the Boulder-Lhasa 
Sister City Project. Recommendations 
stressed the following public health 
needs: improved treatment centers 
within the known disease-endemic 
counties or prefectures for long-term 
follow-up of patients after surgery and 
chemotherapy for both CE and AE 
disease, a better understanding of the 
epidemiology and ecology of trans-
mission, and planning for pilot control 
interventions against both CE and AE 
transmission. NZAID made a detailed 
report of the implementation and ef-
fects of a pilot echinococcosis control 
program (2000–2006) in Datangma 
County, Ganze Tibetan Autonomous 
Prefecture (Sichuan Province). Prob-
lems occurred chieﬂ  y because of poor 
intersectoral cooperation, difﬁ  cult lo-
gistics, cultural antagonism, lack of 
participatory planning, difﬁ  cult access, 
treatment of dogs (with praziquantel), 
vaccination of livestock with the new 
EG95 vaccine (6), and lack of ade-
quate surveillance of dog and livestock 
infection levels. The report indicated 
how many of these difﬁ  culties could be 
overcome. Consequently, the People’s 
Republic of China MoH and provin-
cial disease control networks approved 
funding in July 2006 to initiate pilot 
intervention programs against echi-
nococcosis in 17 Tibetan autonomous 
counties of northwest Sichuan. Con-
trol options initially focused on regular 
supervised dosing of owned dogs and 
stray dogs (with praziquantel) by local 
operatives from district disease con-
trol centers and on improving health 
education at primary healthcare lev-
els. Surveillance relies on measuring 
regularly the degree of Echinococcus 
infection in dogs by using a coproanti-
gen test. Also, a speciﬁ  c age cohort of 
schoolchildren is monitored by ultra-
sound and serologic testing each year 
to determine changes in the prevalence 
of the 2 diseases. Albendazole is pro-
vided free, and the cost of surgery 
for hydatid disease is also subsidized 
through the new National Rural Coop-
erative Medical Insurance System.
In addition to the major public 
health problem now being recognized 
for echinococcosis in Tibetan commu-
nities, their general health indices are 
low (higher prevalence of tuberculo-
sis, bone diseases such as arthritis, and 
poorer health in general) because of 
living and working at altitudes >4,000 
m, compared with those in most other 
areas of China. Access and outreach 
should be improved (in conjunction 
with animal health initiatives) (10) for 
effective delivery of treatment, vacci-
nation, and health education packages 
to these largely scattered and margin-
alized pastoral communities. 
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